Simplify Asset Management Inc. Neurocrine Biosciences Inc Transaction History
Simplify Asset Management Inc.
- $1.77 Billion
- Q3 2025
A detailed history of Simplify Asset Management Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Simplify Asset Management Inc. holds 36,624 shares of NBIX stock, worth $5.22 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
36,624
Previous 46,497
21.23%
Holding current value
$5.22 Million
Previous $5.84 Million
12.03%
% of portfolio
0.29%
Previous 0.34%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
662Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.02 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$794 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$637 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$440 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...